Nurse Practitioner | Nurse Practitioner Bio

Debra Spoljaric, RN, MSN, CPNP, FNP-C

Siteman Cancer Center
Hematology and Oncology
Spoljaric_d@wustl.edu
Phone: 314-747-3046


Education

  • University of Massachusetts-Boston, post-Masters certificate Family Nurse Practitioner, 2015
  • University of Missouri-St. Louis, Master of Science in Nursing, 2003
  • Webster University, Bachelor of Science in Nursing, 1995
  • Jewish Hospital School of Nursing, Diploma in Nursing, 1991

Licensure and Board Certification

  • Certified Family Nurse Practitioner by American Association of Nurse Practitioners since 2016
  • Certified Pediatric Nurse practitioner – Primary Care by the Pediatric Nursing Certification Board since 2003

Honors & Awards

  • Hugs for Heroes: A Heartfelt way to thank your healthcare hero, from patients family (June 2014)
  • St. Louis Pediatric Nurse Practitioner Association Nurse Practitioner of the Year Award (2014)
  • Guardian of Childhood nominee and winner (SLCH), for the passion you show to your patients and families (2016)
  • Sigma Theta Tau – Nu Chi Chapter
  • Quality Service Award-St. Louis Children’s Hospital (1996 & 1999)
  • BJC Home Care Pediatric Employee of the Year (2003)
  • Nominated for Missouri March of Dimes Nurse of the Year award for the category of Advance Practice Nurse(2013)

Publications

  • Spoljaric, D and Sylvain G., 2020 (Winter). Reproductive Outcomes Research and the Pediatric Cancer Survivor. Association of pediatric hematology/oncology nurses newsletter 34 (4) 21-22.
  • Hauff, M, Abel, R, Hersh, J, et al. Adolescent survivors’ information needs for transitions to postsecondary education and employment. Pediatr Blood Cancer. 2019; 66:e27547. https://doi.org/10.1002/pbc.27547
  • Warrington, N. M., Jingqin Luo, T. S., McKinstry, R.C., Parkin, P.C., Ganzhorn, S., Spoljaric, D. et al., and Joshua B. Rubin. The cyclic AMP pathway is a sex-specific modifier of glioma risk in type 1 neurofibromatosis patients. Cancer Research (2015) 75(1): 16-21.
  • Spoljaric, D. 2013, (Summer). Bevacizumab (Avastin) in Clinical Trials and Nursing Care Related to Bleeding Problems. Association of pediatric hematology/oncology nurses newsletter 27 (2) 6.
  • Abstract QL-09: “Barriers to Participation In A Neuro-Oncology Education And Support Group”. Spoljaric, Isenberg, Whittington, Hauff, King. 15th International Symposium on Pediatric Neuro-Oncology, June 24-27, 2012. Toronto, Ontario, Canada. Journal of Neuro-Oncology (2012) 14 (suppl 1): i125-i139.
  • Abstract Multi09: “Educational Needs of Pediatric Neuro-Oncology Families Can Be Addressed In A Support Group Setting”. Spoljaric, Sandvoss, Isenberg. 14th International Symposium on Pediatric Neuro-Oncology, June 20-23, 2010. Vienna, Austria. Journal of Neuro-Oncology (2010) 12 (6).
  • Abstract Multi1: “A Formal Educational Advocacy Program Is Needed By Families Of Children With Brain Tumors”. Spoljaric, Serice, Hauff, King. 13th International Symposium on Pediatric Neuro-Oncology, June 29-July 2, 2008. Chicago, IL, USA. Journal of Neuro-Oncology (2008) 10 (3):369-517.
  • Neurofibromatosis study trial parent journal. Created information journal for families, 2008.
  • Radiation oncology parent journal. Created information journal for families, 2008.
  • DeBaun,M., Spoljaric, D., Heigham, M. “Treatment of children with neuropathic pain due to cancer: A guideline using methadone. Originated 2002, revised 2004.
© 2021 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130